HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION financial statements, including revenue, expenses, profit, and loss
The total revenue of 600829 for the last quarter is 2.68 B CNY, and it's 12.88% higher compared to the previous quarter. The net income of Q3 24 is 70.81 M CNY.